High growth is also much easier to log in a small business than in a Reliance.
Common items between Centre and states - bread, eggs, milk, vegetables, cereals, books and salt - will continue to be exempted.
Indians want change and progress. They should be willing to accept tough decisions, says Sanjeev Nayyar.
The NITI Aayog's vice-chairman's charge holds ground.
Setting up Chinese Industrial Parks in India, increased access to Indian products to bridge the ballooning trade deficit besides border issues was expected to figure in Prime Minister Narendra Modi's first meeting with Chinese President Xi Jinping on the sidelines of the BRICS summit.
Sun-Ranbaxy are keen to complete the merger process.
"While the risk of a correction goes up in the near term, on a long-term basis the Indian market is on an absolutely strong footing."
'15, 17 years back we were not even in existence in the US. Today nearly 1/3 of prescriptions written comes from India.' 'India is showing that in a very competitive environment -- like the US and Europe -- our industry is doing very well.'
The S&P BSE Sensex ended 46 points lower at 24,824 and Nifty50 settled at 7,555, down by 8 points after hitting intra-day high of 7,600.45.
Kerry is scheduled to head to India later this month for the fourth annual US-India Strategic Dialogue.
At present, there is no direct air connectivity between India and Myanmar.
Make in India and Swacch Bharat initiatives are going to have tremendous impact on the Home and Personal Care industry.
Capital goods, IT, auto and pharmaceuticals lead gains for the financial year
The 30-share Sensex ended down 604 points at 28,845 and the 50-share Nifty ended down 181 points at 8,757. The Bank Nifty ended down 602 points at 19,146.
On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.
'Macro headwinds are rising for Indian equities in the form of rising commodity prices, especially oil, depreciating rupee, fiscal challenges, election-related uncertainty and upside risks to inflation'
In prior elections, not only have opinion poll forecasts been very different from the results, the error margin has increased over time. One need only look at the charts that show the Sensex half a year before and after the results day for the last six elections. The markets did not change direction in any, says Neelkanth Mishra.
Flaring of tempers comes atop much simmering trouble on clashing views; these stands might now get frozen.
The biotech company's revenues had fallen to as low as Rs 50 cr.
Ranbaxy Laboratories on Wednesday reported widening of its consolidated net loss to Rs 1,029.72 crore (Rs 10.29 billion) for the third quarter ended December 31, 2014
IT majors weakened ahead of the September US jobs data and telecom stocks ended lower
'The mismatch between valuations and fundamentals is startling,' warns Devangshu Datta
In a meeting with the commerce minister, India Inc hammered Sharma on the collapse of investments, structural nature of the current account deficit and stagnant growth in agriculture.
India battles big pharma over cough syrup abuse, reducing supplies
Revival in domestic business should also help overall revenue growth.
The Indian indices also offer one of the lowest dividend yields.
King Salman and Narendra Modi will find common ground to intensify cooperation against jihadi terrorism, says Tarun Vijay, MP.
The broader markets outperformed the benchmark indices- BSE Midcap and Smallcap indices gained 0.4% each
The market is moving up because there is a high degree of speculative retail and operator action. This is rarely a situation sustainable for any lengthy period, says Devangshu Datta.
Automobile sector accounts for the third-highest equity mutual fund contributions.
On the last day of FY!5, the Sensex ended lower by 18.37 points at 27,957.49.
The US Food and Drug Administration (FDA) says it does not follow an India agenda.
But it is likely that campaign spending resulted in some positive activity through this period.
Above normal monsoon forecast and strength in Asian equities lifted sentiments.
The sharp fall in the rupee's value against the dollar during the July-September quarter, it turns out, has come as a boon for corporate earnings.
India Inc will report good set of numbers in Q4.
Nifty50 surged 145 points to close at 8,468 after hitting an intra-day high of 8,475.
Broader markets outperformed with BSE Midcap and BSE Smallcap adding 0.23% and 0.45%, respectively
The 30 share Sensex ended up 183 points at 27,470 and the 50-share Nifty gained 44 points to close at 8,295.
Jonathan Garner, chief Asia and emerging markets equity strategist, Morgan Stanley, gives Samie Modak his assessment of the Indian economy after 3 years of Modi Sarkar.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances